. Introduction
important mechanism contributing to cardiac remodeling [1, 2] . Several studies have associated enhanced levels of In recent years, apoptosis, a gene-regulated process of apoptosis with the pathogenesis of cardiac disease, e.g., in cell self-destruction associated with caspase activation and the loss of cardiomyocytes and neurons leading to heart internucleosomal DNA fragmentation, has emerged as an failure and cardiac conduction system disorders [3] [4] [5] . However, the role of apoptosis in cardiac remodeling is context-dependent and may participate in normal cardiac remodeling as illustrated by the differential regulation of purchased from Charles-River (St.-Constant, Canada) and cardiomyocyte apoptosis between the right and left ventrihoused for at least 1 week before treatment. Food and cles during the post-natal period [6] .
water were administered ad libitum. SHRs (n56 / group) The spontaneously hypertensive rat (SHR) is a model of were randomly assigned to treatment with the selective 21 21 primary hypertension in which an imbalance between cell AT antagonist valsartan (30 mg kg day p.o.; gift of 1 growth and apoptosis favors increased cardiac mass and Novartis, Toronto, Canada) or the angiotensin converting 21 21 DNA content in neonates and adults [7] [8] [9] . Adult SHRs enzyme inhibitor enalapril (30 mg kg day p.o.; Sigma show cardiac fibroblast hyperplasia [10] , a common feature Chemicals, St. Louis, MO, USA) in the drinking water for of pathological cardiac remodeling leading to increased 1, 2 or 4 weeks. Control SHRs and WKY rats received extracellular matrix deposition and cardiac fibrosis [11, 12] .
vehicle. Systolic blood pressure was determined by the With aging, the hypertensive heart also shows increased tail-cuff method at 12 and 26 days of treatment (n56 / cardiomyocyte apoptosis [4, 13, 14] , a feature that is atgroup) and tissues were isolated after 1 and 2 weeks as we tenuated following angiotensin converting enzyme inhibidescribed previously [16] . Briefly, rats were anesthetized 21 tion or angiotensin II type 1 (AT ) receptor blockade with a single i.m. injection of ketamine (80 mg kg ; 1 21 [4, 10, 14, 15] . Liu et al. [10] reported an age-dependent Ayerst, Guelph, Canada), xylazine (4 mg kg ; Bayer,
21
increase in cardiac apoptosis in young SHRs, mainly in Etobicoke, Canada), and acepromazine (2 mg kg ; cardiomyocytes, concomitant with the development of Ayerst, Montreal, Canada), and killed by exsanguination fibroblast hyperplasia. Prophylactic treatment of hypertenvia the jugular vein. Both ventricles were isolated together, sion with the angiotensin converting enzyme inhibitor weighed and an equatorial cross-section (3 mm) was fixed ramipril reduces cardiac apoptosis in the long term and in paraformaldehyde (4%). In SHRs killed after 4 weeks of prevents the development of fibroblast hyperplasia [10] .
treatment and age-matched WKY (n56 / group) anesthesia Likewise, initiating hydralazine treatment during the prewas followed by an i.v. injection of 1.5 ml KCl (100 mmol 21 hypertensive phase can prevent the development of cardiac l ) via the vena cava to induce diastolic cardiac arrest. hyperplasia in SHRs (deBlois et al., unpublished data). In Ventricles were isolated together, weighed and fixed contrast, hydralazine does not reverse cardiac hyperplasia overnight in 4% paraformaldehyde. Equatorial cross-secin adult SHRs [16] . A key question is whether established tions of ventricles were paraffin-embedded. All animal fibroblast hyperplasia can be reversed in the hypertensive manipulations were conducted in accordance with the Care adult. We previously reported that a transient increase in
and Use of Laboratory Animals guidelines published by apoptosis occurs at the onset of cardiac hypertrophy the National Institutes of Health (NIH). regression in SHRs [16] . In this model, internucleosomal fragmentation of ventricular DNA peaks at 1 week of 2 .2. Hypertrophy and hyperplasia measurements treatment with an AT receptor antagonist, or at 2 weeks 1 of treatment with an equipotent antihypertensive dose of an
We used the NIH Image 1.61 program (http: / / rsb.inangiotensin converting enzyme inhibitor. Current evidence fo.nih.gov / nih-image / ) to measure the cross-sectional area suggests that angiotensin II regulation of apoptosis in the of the ventricles, ventricular chambers and cardiomyocytes heart is cell type-specific. In vitro, angiotensin II increases at 4 weeks. Three sets of randomly chosen pictures (from cardiomyocyte apoptosis, an effect dependent on AT the left and right ventricular sub-epicardium, sub-endo-1 receptor activation [17, 18] . In contrast, cultured cardiac cardium and mid-myocardium) were captured from hemafibroblasts undergo AT receptor-dependent proliferation toxylin stained histological sections and digitally en-1 in response to angiotensin II [19] . hanced. The total number of cardiomyocytes within each We therefore postulated that the early phase of cardiac ventricle was assessed stereologically as per Anversa et al. hypertrophy regression induced by inhibitors of the renin- [20] . A similar procedure was used to calculate total angiotensin system in adult SHR involved the selective non-cardiomyocyte number with the exception that the deletion of fibroblasts via apoptosis. The present study area covered by the (unstained) cell body of non-carprovides evidence for a beneficial role of selective apopdiomyocytes was estimated using the average nuclear tosis up-regulation in cardiac remodeling induced by antilength measurements (10.560.3 mm in controls; no change hypertensive treatments, namely the reversal of fibroblast with treatment), extended half a time in the x and y axes hyperplasia.
around each nucleus.
.3. DEVDase activity . Methods
Ventricles were pulverized in liquid nitrogen and an 2 .1. Animal procedures aliquot (5 mg) was lysed to measure DEVDase activity using the fluorogenic substrate DEVD-AMC (40 mM) in Forty-two male SHRs and six male Wistar-Kyoto the presence or absence of the Ac-DEVD-CHO (1 mM), a (WKY) rats (10 weeks old; weighing |250 g) were caspase-3 inhibitor as previously described [21] . Caspase-3-like activity was defined as the Ac-DEVD-CHO-sensipropidium iodide (ICN Biomedicals, Aurora, OH, USA) tive activity.
was used for total cardiac nuclei staining. In a duplicate set 21 of sections, endothelial cells were labeled using 5 mg ml 2 .4. Expression of apoptosis-regulatory proteins TRITC-labeled lectin (Bandeiraea simplicifolia; Sigma Chemicals) and TUNEL positive nuclei were labeled using
21
The protein levels of active caspase-3 17-20 kDa 0.1 mg ml AMCA-labeled streptavidin (Vector Labfragments, Bcl-2 and Bax in cardiac tissue were examined oratories). Appropriate filters were used to quantify labeled by Western Blot analysis. Total heart was pulverized in cells by fluorescence microscopy separately in right and liquid nitrogen and a 50 mg aliquot was lysed in extraction left ventricles. All TUNEL-positive nuclei (cardiomyocyte,
buffer [10 mmol l Tris-HCl, pH 7.5, 1% Triton X-100, non-cardiomyocyte: endothelial and fibroblast) in each 21 21 4 mmol l b-glycerophosphate, 4 mmol l sodium section were counted. The epicardium was analyzed separ- 21 21 fluoride, 1 mmol l EDTA, 1 mmol l EGTA, 200 mmol ately. Total number of cell specific nuclei per cross-section 21 21 l sodium orthophosphate, 51 mmol l benzamidine, 0.5 was estimated by counting profiles in 3 randomly chosen 21 21 2 mmol l phenylmethylsulfonylfluoride, 21 mmol l fields from both ventricles (2503; 0.02 mm / field) and 21 21 leupeptin, 5 mmol l dithiothreitol (DTT) and 1 mmol l multiplying the average numerical density by the ventricumicrosystin (Sigma-Aldrich, Oakville, Canada)]. Western lar cross-sectional area. An average of 500 endothelial cell Blot was carried out with equal amounts of proteins (25 profiles were counted for each rat and results were 2 mg) loaded onto a 15% sodium dodecyl sulfate (SDS)-expressed as number of capillaries / mm . In the epicarpolyacrylamide gel and transferred to Hybond-C extra dium, all nuclei were counted. A separate set if sections membrane (Amersham Bioscience, London, UK). Memwere stained with Sirius red to evaluate the percentage of branes were hybridized with anti-caspase-3 (1:1000; BD ventricular area occupied by collagen [22] . Pharmingen, Mississauga, Canada), anti-Bax or anti-Bcl-2 (1:1000; Santa-Cruz Biotech, Santa Cruz, CA, USA) 2 .6. Statistical analysis antibodies followed by incubation with goat anti-rabbit (caspase-3) or goat anti-mouse (Bax, Bcl-2) horseradish
Results were analyzed using analysis of variance and peroxidase-conjugated secondary antibodies (1:2000; Sanunpaired Student's t-test with Bonferroni correction for ta-Cruz Biotech) according to manufacturer's protocol. multiple comparisons where appropriate. TUNEL assay Membranes were then incubated with ECL Plus (Life was analyzed with the nonparametric Mann-Whitney test. Science Products, Boston, MA, USA), exposed to film and Values are presented as mean6S.E.M. P,0.05 was condeveloped. The image was digitized and band intensity sidered statistically significant. was quantified using NIH Image 1.61 program. For caspase-3, the 32 kDa (procaspase-3) and 17-20 kDa (indicative of enzyme activation) fragments were mea-3 . Results sured.
Systolic blood pressure (mmHg) was significantly de-2 .5. Immunohistochemistry creased by therapy after 12 days (controls: 20669; valsartan: 166610; enalapril: 15569) and 26 days (controls: Quantification of apoptotic nuclei was conducted in 212610; valsartan: 15268; enalapril: 14869). Body deparaffinized ventricular cross-sections (5 mm) using a weight was not significantly affected after 4 weeks of three-step in situ fluorescent labeling protocol as per treatment with valsartan (285612 g) or enalapril (277611 Cigola et al. [17] with minor modifications. As a first step, g), compared with controls (295614 g), whereas left in situ terminal deoxynucleotidyl transferase (tdt)-mediventricular weight to body weight ratio was significantly ated dUTP-biotin nick end labeling (TUNEL) of nuclei reduced with valsartan (.9%) and enalapril (.17%). was used as a marker of apoptosis. Modifications from the Morphological data obtained on equatorial sections of published protocol [17] included pre-incubation at room diastole-arrested hearts are shown in Table 1 . As compared temperature for 15 min in a 0.1% saponin-EGTA solution, to WKY rats, untreated SHRs showed increased left amount of tdt enzyme (20 units; Roche, Indianapolis, IN, ventricular cross-sectional area and cardiomyocyte cross-
USA), biotin-16-dUTP (0.5 nmol l ; Roche) and FITCsectional area. SHRs tended to have a (non-significant) 21 labeled extravidin (0.06 mg ml ; Sigma Chemicals). larger chamber cross-sectional are in left ventricle as Negative controls had water instead of tdt. As a second compared to WKY rats. Unexpectedly, the only difference step, immunoreactivity for a-sarcomeric actin was used as in relative collagen content was in the right ventricle of a marker for cardiomyocytes. A primary mouse IgG WKY rats where there was a slight increase over SHRs. antibody directed against a-sarcomeric actin (1:40; 5C5 After 4 weeks, valsartan tended to reduce and enalapril clone, Sigma Chemicals) and a TRITC-labeled goat IgG completely normalized left ventricular cross-sectional area secondary antibody directed against mouse IgG (1:100; without affecting ventricular chamber size or right ven-
Sigma Chemicals) were used. As a third step, 5 nmol l tricular parameters. Valsartan and enalapril significantly Fig. 1C, D) . affecting the total number of cardiomyocyte nuclei at 4 The absolute number of epicardial cells per cross-section at weeks (Fig. 1A) . Thus, the ratio of cardiomyocyte to 4 weeks was reduced, though the change was not signifinon-cardiomyocyte nuclei, which was low in controls cant (valsartan: 559685; enalapril: 676658; controls: (0.1760.01), was normalized with valsartan (0.2460.01; 756691; NS). Our previous time course studies showed that DNA fragmentation indicative of apoptosis is maximally increased in the SHR heart after 1 week of AT antagonist 1 treatment and 2 weeks of angiotensin converting enzyme inhibitor treatment during regression of hypertrophy [16] . Thus, these time points for valsartan (1 week) and enalapril (2 weeks) were selected for apoptosis study and in situ determination of cell type undergoing apoptosis in the ventricles.
Consistent with these previous observations, ventricular DEVDase (caspase-3-like) activity was increased by more than 4.5-fold after 1 week of valsartan or 2 weeks of enalapril treatment (Fig. 2A) . These results were corroborated with immunoblot analyses showing transient 3.6-and 4.2-fold increases in caspase-3 cleavage fragments (bands at 17-20 kDa) with valsartan and enalapril, respectively, without alteration in pro-caspase-3 (32 kDa) expression levels (not shown). In addition, measurement of cardiac pro-(Bax) and anti-apoptotic (Bcl-2) protein levels showed significant 3.4-and 3.2-fold increases in the Bax to Bcl-2 ratio with valsartan and enalapril, respectively (Fig.  2B) . Fig. 3A shows a representative photomicrograph of an area within the myocardium in which all (propidium iodide-positive) nuclei appear in bright red, well delineated spots, whereas nuclei within the a-sarcomeric actin-positive area (diffuse red area) were identified as cardiomyocyte nuclei. In Fig. 3B , the same field examined under a green filter to detect FITC-labeling shows a TUNEL-positive non-cardiomyocyte nucleus. For each animal, a subset of sections was stained for identification of endothelial cells using lectin as a marker (bright red spots in Fig. 3C ). In Fig. 3D , the same field examined under a blue filter to detect AMCA-labeling shows a TUNEL-positive, lectin-negative nucleus, considered as an apoptotic fibroblast. Treatment with valsartan for 1 week or enalapril for 2 weeks each caused a significant twofold increase in TUNEL-positive fibroblasts (Fig. 4A) selectively in the interstitium of the left ventricle. In contrast, TUNEL-positive endothelial nuclei remained unchanged versus controls (Fig. 4B) . TUNEL-positive fibroblasts returned to basal values (0.02660.005%) after 4 weeks of valsartan (0.03360.003%) or enalapril (0.03460.004%) treatment. TUNEL-positive cardiomyocyte nuclei were increased with enalapril at 2 weeks (by 75% in the left ventricle only) (Fig. 4C) . Valsartan-treated hearts at 1 week was restricted to interstitial fibroblasts in the left ventricle of SHRs treated with valsartan or enalapril. As a result, fibroblast hyperplasia in the adult SHR was normalized within 4 weeks of treatment, down to levels seen in WKY rats. Apoptosis increase was transient even though antihypertensive treatments were maintained, consistent with our previous observations [16] . Both drugs had a tendency to transiently increase TUNEL staining also in cardiomyocytes (significant with enalapril). The cumulative effect was marginal, however, since the total number of cardiomyocyte nuclei was not significantly decreased after 4 weeks of treatment in the left ventricle. Administration of quinapril decreases the percentage of tetraploid cardiomyocytes in SHRs [23] , an effect that reflects either nuclear division or polyploid cell deletion. Cardiomyocyte polyploid nuclei may be removed by apoptosis during treatment with renin-angiotensin system inhibitors. Alternatively, TUNEL staining may label nuclei undergoing DNA repair [24] . After the 4-week treatments, the number of cardiomyocytes in the right and left ventricles of SHRs remained unchanged and higher than in WKY rats, possibly reflecting compensated cardiac hypertrophy in SHR at that age. In humans, right septal endomyocardial biopsies from hypertensive patients show greater caspase-3 immunoreactivity, Bax to Bcl-2 protein ratio and TUNEL staining in both cardiomyocytes and interstitial fibroblasts as compared to tissues from normotensive volunteers [25] . These high levels of apoptosis in cardiomyocytes and interstitial fibroblasts are attenuated significantly, though not normalized, following administration of losartan for 12 months. The discrepancy with the present results may reflect species specificities, different stages of the disease or time-dependent regulation of cardiac apoptosis during treatment.
The beneficial effects of angiotensin pathway inhibitors include the amelioration of oxygen diffusion in the left ventricular myocardium. Previous reports show that cardiac capillaries are not decreased in SHRs receiving reninangiotensin system inhibitors [26, 27] . Consistent with this, the treatments in this study did not increase TUNEL- At the age examined, the left ventricles of SHRs did not show evidence of collagen accumulation as compared to a return to basal levels at 4 weeks for both treatments WKY rats possibly due to the relatively recent onset of (valsartan: 3763%; enalapril: 3563%; age-matched conhypertension in SHRs. A significant increase in left trols: 3861%; NS). Both ventricles showed similar freventricular collagen content in SHR versus WKY has been quencies of TUNEL-positive epicardial cells (not shown).
reported in some but not all studies [29, 30] . Consistent with a lack of enhanced collagen deposition in untreated SHRs left ventricles, these tissues showed no reduction in 4 . Discussion relative collagen tissue content after 4 weeks of treatment. Since left ventricular mass was reduced, these data suggest The present results indicate significant cell deletion by a proportional degradation of myocardial fibrillar collagen apoptosis during onset of cardiac hypertrophy regression within the 4-week treatments. Varo et al. [31] recently reported that AT receptor blockade for 14 weeks stimuangiotensin-converting enzyme [41] and AT receptors 1 1 lates collagenase activity and reduces fibrosis in SHR left [42] . Considering the present findings, it is intriguing to ventricles. As an additional mechanism, the present data speculate that the suppression of post-operative pericardial suggest that a reduction of fibroblast hyperplasia may fibrosis by AT receptor blockade [43] involves enhanced 1 contribute to decreased myocardial extracellular matrix mesothelial cell death by apoptosis. Also intriguing, are the mass.
high basal levels of TUNEL-positive mesothelial cells The induction of fibroblast apoptosis and the reduction (30% range), which may suggest a high turnover rate. in ventricular cross-sectional area occurred only in the left Several studies showed that inhibition of the reninventricle, suggesting a possible causal relationship between angiotensin system decreases cardiomyocyte apoptosis in these two processes. The absence of right ventricular hypertension [4, 10, 14, 15] . Considering these findings with apoptosis also suggests a role for blood pressure reduction.
the present data, we propose that the beneficial cardiac It is important to note, however, that effective antihypereffects of angiotensin II pathway inhibitors may involve tensive treatment with hydralazine does not induce cardiac cell type-specific regulation of apoptosis, with an early apoptosis or mass regression, suggesting pressure independecrease in fibroblast survival and a long-term increase in dent influences [16] . We previously reported that transient cardiomyocyte survival. If confirmed in humans, the ability apoptosis induction during regression of aortic hypertrophy to reduce fibroblast hyperplasia via apoptosis may have is dependent on pro-apoptotic AT receptors for angiotenimportant implications in the treatment of advanced car- Heart and Stroke Foundation of Canada / CIHR. We would reactive oxygen species generation, and growth factor like to acknowledge the help of Dr. Maria Antonia Fortuno expression [33, 34] . One candidate is insulin-like growth and Dr. Martin G. Sirois in developing the immunofactor 1, which is induced by angiotensin II [35] and which chemistry protocols and of Marie-France Ross in conductinhibits apoptosis in cardiac fibroblasts via a mechanism ing the quantitative image analysis. up-stream of caspase-3 but independent of Bax or Bcl-2 expression [36] . Cardiac Bax to Bcl-2 ratio was increased during apoptosis in the present study, however, suggesting R eferences an alternative pathway. Tissue inhibitor of metalloproteinase-4 (TIMP-4), which shows dysregulated
